Cargando…

Revascularisation for Ischaemic Cardiomyopathy

Coronary artery disease is a leading cause of heart failure with reduced ejection fraction. Coronary artery bypass grafting appears to provide clinical benefits such as improvements in quality of life, reductions in readmissions and MI, and favourable effects on long-term mortality; however, there i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li Kam Wa, Matthew E, Assar, Saba Z, Kirtane, Ajay J, Perera, Divaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2023
Materias:	Coronary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466461/ https://www.ncbi.nlm.nih.gov/pubmed/37655258 http://dx.doi.org/10.15420/icr.2023.06

Ejemplares similares

To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic Cardiomyopathy
por: Briceno, Natalia, et al.
Publicado: (2016)

How to select patients requiring coronary revascularisation using coronary physiology
por: Modi, Bhavik, et al.
Publicado: (2021)

FLOWER-MI and the root of the problem with non-culprit revascularisation
por: Li Kam Wa, Matthew E, et al.
Publicado: (2021)

Minimally Invasive Coronary Revascularisation Surgery: A Focused Review of the Available Literature
por: Van Praet, Karel M, et al.
Publicado: (2021)

Sudden Cardiac Death in Ischaemic Cardiomyopathy and the Primary Prevention ICD: Time for a More a Personalised Approach?
por: Ezad, Saad M, et al.
Publicado: (2023)

Iterative Improvement and Marginal Gains in Coronary Revascularisation: Is Robot-assisted Percutaneous Coronary Intervention the New Hope?
por: De Silva, Kalpa, et al.
Publicado: (2020)

Functionally Complete Coronary Revascularisation in Patients Presenting with ST-elevation MI and Multivessel Coronary Artery Disease
por: Di Serafino, Luigi, et al.
Publicado: (2021)

Impaired autonomic function after incomplete revascularisation
por: Armstrong, Richard, et al.
Publicado: (2021)

Coronary artery restenosis and target lesion revascularisation in women by pregnancy history
por: Pehrson, Moa, et al.
Publicado: (2023)

Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions
por: Sharma, Vinoda, et al.
Publicado: (2015)

Mortality after multivessel revascularisation involving the proximal left anterior descending artery
por: Ono, Masafumi, et al.
Publicado: (2022)

The ischaemic constellation: an alternative to the ischaemic cascade—implications for the validation of new ischaemic tests
por: Maznyczka, Annette, et al.
Publicado: (2015)

Propensity-matched analysis of long-term clinical results after ostial circumflex revascularisation
por: Espejo-Paeres, Carolina, et al.
Publicado: (2023)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?
por: Benenati, Stefano, et al.
Publicado: (2023)

Association of protein-energy wasting and inflammation status with mortality after coronary revascularisation in patients on haemodialysis
por: Kumada, Yoshitaka, et al.
Publicado: (2020)

Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy
por: Stewart, Ralph A H, et al.
Publicado: (2018)

Comorbidity phenotypes and risk of mortality in patients with ischaemic heart disease in the UK
por: Crowe, Francesca, et al.
Publicado: (2020)

Impact of complete revascularization in coronary artery bypass grafting for ischemic cardiomyopathy
por: Nakae, Masaro, et al.
Publicado: (2023)

Angiographic control versus ischaemia-driven management of patients undergoing percutaneous revascularisation of the unprotected left main coronary artery with second-generation drug-eluting stents: rationale and design of the PULSE trial
por: De Filippo, Ovidio, et al.
Publicado: (2020)

Impact of COVID‐19 pandemic on the management of nonculprit lesions in patients presenting with ST‐elevation myocardial infarction: Outcomes from the pan‐London heart attack centers
por: Demir, Ozan M., et al.
Publicado: (2021)

Outcomes of ischaemic mitral regurgitation in anterior versus inferior ST elevation myocardial infarction
por: Mentias, Amgad, et al.
Publicado: (2016)

Left ventricular function and survival in ischemic cardiomyopathy: Implications for surgical ventricular restoration
por: Adhyapak, Srilakshmi M., et al.
Publicado: (2021)

Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction
por: Lindholm, Daniel, et al.
Publicado: (2019)

Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real‐world comparative analysis
por: Beohar, Nirat, et al.
Publicado: (2022)

How to Diagnose and Manage Angina Without Obstructive Coronary Artery Disease: Lessons from the British Heart Foundation CorMicA Trial
por: Ford, Thomas J, et al.
Publicado: (2019)

Antegrade Chronic Total Occlusion Strategies: A Technical Focus for 2020
por: Creaney, Calum, et al.
Publicado: (2020)

Is It Really Safe to Discontinue Antiplatelet Therapy 12 Months After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation?
por: Abdulrahman, Balen, et al.
Publicado: (2023)

Coronary Stent Placement in an Interarterial Anomalous Right Coronary Artery: An Alternative Approach in a Multimorbid High-risk Surgical Patient
por: Simon, Erik J, et al.
Publicado: (2022)

Primary versus iatrogenic (post-PCI) coronary microvascular dysfunction: a wire-based multimodal comparison
por: Hasdemir, Hakan, et al.
Publicado: (2023)

1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA)
por: Ford, Thomas J., et al.
Publicado: (2020)

Influence of cardiovascular risk factors on infarct size and interaction with mechanical ischaemic postconditioning in ST-elevation myocardial infarction
por: Pichot, Sophie, et al.
Publicado: (2015)

Impact of recurrent ischaemic and bleeding events on quality of life in patients with acute coronary syndrome: Insights from the FORCE-ACS registry
por: van der Sangen, Niels M R, et al.
Publicado: (2023)

Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells
por: O'Neill, Christina L, et al.
Publicado: (2012)

CRT-100.96 Effect of COVID-19 Pandemic on Six-Month Mortality and Clinical Outcomes of Patients With ST-Elevation Myocardial Infarction
por: Elakabawi, Karim, et al.
Publicado: (2023)

CRT-100.87 Impact of COVID 19 on Patients Admitted for ACS: A Nationwide Inpatient Sample Database Study
por: Patel, Jalpan, et al.
Publicado: (2023)

Dovetailing Intra-coronary Imaging and Physiology … the True Gold Standard
por: De Silva, Kalpa
Publicado: (2023)

Sex-specific Inequalities in the Treatment of Severely Calcified Coronary Lesions: A Sub-analysis of the PREPARE-CALC Trial
por: Fitzgerald, Sean, et al.
Publicado: (2023)

Procedural and Technological Innovations Facilitating Ultra-low Contrast Percutaneous Coronary Interventions
por: Hennessey, Breda, et al.
Publicado: (2023)

Long-term Outcomes for Drug-eluting Balloons versus Drug-eluting Stents in the Treatment of Small Vessel Coronary Artery Disease: A Systematic Review and Meta-analysis
por: Murphy, Greg, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hgh9jl2i7jn5o8nmdqn10d0vng